
Cardiovascular diseases (CVDs) remain the leading cause of global mortality, accounting for approximately one-third of all deaths. The growing prevalence of CVDs underscores the urgent need for novel diagnostic and therapeutic approaches. Circular RNAs (circRNAs), a class of single-stranded RNA molecules formed through back-splicing, have attracted considerable attention as potential biomarkers and therapeutic targets due to their unique characteristics. Unlike linear RNAs, circRNAs lack free 3′ and 5′ ends, making them highly resistant to exonuclease degradation and thereby markedly more stable, with a half-life approximately 2–5 times longer than that of linear RNAs. Their stability, tissue- and disease-specific expression patterns, evolutionary conservation, and responsiveness to pathological stimuli enable them to regulate key biological processes such as apoptosis, metabolism, and inflammation. Growing evidence suggests that circRNAs play a role in the pathogenesis of CVDs: circRNA expression levels differ between cardiac tissues of healthy individuals and those of patients with various CVDs; in arterial hypertension, circRNAs 0037909 and 0037911 are closely associated with elevated blood pressure; following myocardial infarction, circRNA FoxO3 exacerbates myocardial injury, whereas circ-Amotl1 attenuates apoptosis and reduces adverse remodeling; in myocardial hypertrophy, knockdown of circSlc8a1 decreases hypertrophy, while circRNA 000203 promotes it by modulating hypertrophic gene expression; in heart failure, an inverse correlation between MICRA levels and left ventricular ejection fraction has been identified, making MICRA a valuable early indicator of left ventricular dysfunction. This review provides a detailed analysis of circRNAs in CVDs, including their biogenesis, molecular mechanisms, and functional roles. It also evaluates their potential as diagnostic and prognostic biomarkers, and discusses therapeutic advances based on circRNAs (synthetic circRNA sponges) and low-molecular-weight drugs. However, despite these promising findings, numerous challenges remain unresolved, including tissue-specific delivery of circRNAs and control of their complex pleiotropic effects. Furthermore, most data on the role of circRNAs, particularly in CVDs, have been obtained from preclinical studies, often involving animal models or in vitro systems. Therefore, further validation through comprehensive preclinical research and well-designed clinical trials is essential. Successful future integration of circRNA-based tools into clinical practice could fundamentally transform CVD management, enabling earlier detection and more personalized treatment strategies.
The number of malignant neoplasms of the head and neck organs, as well as all oncological diseases, continues to grow every year. The number of common processes remains at a high level. A significant problem of common oncological processes of the head and neck is bleeding, especially recurrent ones. The development of interventional diagnostic and treatment methods can solve many problems, but, unfortunately, they do not always lead to the expected hemostasis. One of the causes of recurrent bleeding is the presence of multiple anastomoses between the carotid arteries of the ipsilateral and controlateral sides. In this article, we present cases where branches from the vertebral artery were significant and hemostasis could not be achieved without their embolization.
The article provides information about the establishment and operation of the first state-owned Medical School under the Pharmacy Order. Some archival data on the educational process, "medicinal" and "apothecary" students, heads of the Apothecary Order and possible teachers of the School.
Currently, 95 % of herniological operations are performed using mesh implants. The key step in performing the operation is the choice of mesh fixation method. At the moment, there is no longer any question that the choice of fixation technique determines the time of surgical treatment, as well as the course of the postoperative period: the severity of pain, the number of early and late postoperative complications, and the frequency of relapses. Economic efficiency also plays an important role, especially in laparoscopic operations. Currently, the main methods of fixation are single-row or continuous sutures for open operations and the use of hernial staplers, both titanium and absorbable staples, for laparoscopic operations. These methods are not without drawbacks and have their own complications and selection criteria. The fixation method using one-component synthetic glue is gaining increasing popularity. We analyzed the method of fixing meshes using Glubran 2 glue in patients with various types of hernias. Purpose of the study. To prove the effectiveness and feasibility of using one-component surgical glue for fixing mesh implants on open and laparoscopic hernia repairs. Material and methods. The study included 148 male andfemale patients aged 18 to 84 years. with the presence of inguinal, inguinal-scrotal, umbilical, field surgical and ventral hernias, with hernial orifices measuring up to 10 cm. Those admitted to the university clinic of the Russian University of Medicine in 2023-2025. The main group consisted of 77 patients in whom fixation was performed using Glubran 2 surgical glue. The comparison group consisted of 71 patients in whom mesh fixation was performed with separate interrupted or continuous sutures during open operations or with a herniostapler during laparoscopic operations. Results. The fixation method using Glubran 2 glue has proven its effectiveness and feasibility in both open and laparoscopic operations. When using glue, there was a significant reduction in surgical time due to the speed of the method and reduced the risk of developing intraoperative complications. There was a significant decrease in pain in the early postoperative period, which significantly led to a decrease in late postoperative complications and the occurrence of chronic pain. The economic efficiency of the adhesive fixation method has been proven. Conclusions. The method of fixation using Glubran 2 glue for both open and laparoscopic operations has a number of advantages. There is a decrease in surgical time, a decrease in the risk of intraoperative complications, a decrease in pain in the early postoperative period and a decrease in the risk of chronic pain. The adhesive fixation method is cost-effective in comparison with classical methods.
Delirium in patients in the intensive care units (ICU) remains one of the most frequent and clinically significant complications of hospitalization. The frequency of delirium ranges from 15 to 80 % and leads to an increase in the duration of stay in the ICU, the total number of days of hospitalization, and an increase in mortality. Virtual reality (VR) is a promising method of non-pharmacological prevention of delirium in patients in the ICU. Aim of the study. To evaluate the effect of virtual reality on the frequency of delirium and clinical outcomes in patients in the ICU. Material and methods. A randomized controlled trial was conducted at the V.V. Veresaev City Clinical Hospital. Patients in the intensive care unit who met the inclusion criteria (n = 380) were divided into two groups: the first group received ABCDEF delirium prevention, while the second group received VR stimulation using special helmets in addition to ABCDEF. The primary endpoint was the incidence of delirium. The secondary endpoints were the duration and severity of delirium. Results. Good tolerability of VR was noted, all patients of the 2 nd group completed the full course of VR. Delirium developed in 55 (28.9 %) patients in the group of standard therapy and in 30 (15.8 %) patients in the group using VR, the difference is statistically significant. Delirium in the control group of patients was more severe than in the group using VR-stimulation (p < 0.05). The duration of delirium was 48 hours in the 1 st group and 24 hours in the 2 nd group, which indicates the effectiveness of VR in reducing the duration of delirium. Conclusion. The VR method can be considered as an additional tool for non-pharmacological prevention of delirium in patients in the ICU.